Chapel-en-le-Frith, UK, February 15, 2005 - Peakdale Molecular has launched its fourth Peakexplorer GPCR (G-protein coupled receptor) library featuring more than 1,100 compounds specifically designed, synthesised and characterised for screening against GPCR targets. This latest library has been created through the assessment of seven chemotypes intended to target GPCRs and includes a novel, proprietary Peakdale chemotype specifically designed to take advantage of the Company’s aminergic GPCR pharmacophore know-how.
